Joseph Mccune: Clinical Trials

1 trial sponsored by Joseph Mccune, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Joseph Mccune: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
depot leuprolide acetate 3.75 mg, Placebo - Lupus Erythematosus, Systemic, Systemic Vasculitis
Phase 3TerminatedJoseph Mccune142011-05-012017-06-27

Conditions studied

Lupus Erythematosus, Systemic (1)  ·  Systemic Vasculitis (1)

Interventions

Leuprolide (1)

Countries

United States (1)

Top investigators

William J McCune, M.D. (1)

NIH funding

R01HD066139 (1)